Cleared Traditional

K260092 - Vista AI Scan

K260092 is an FDA 510(k) clearance for Vista AI Scan, manufactured by Vista AI, Inc.. The device is a Class 2 Radiology device with product code LNH cleared through the Traditional 510(k) pathway after a 268-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2026
Decision
268d
Days
Class 2
Risk

K260092 is an FDA 510(k) clearance for the Vista AI Scan. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Vista AI, Inc. (Palo Alto, US). The FDA issued a Cleared decision on October 7, 2026 after a review of 268 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K260092

510(k) Number K260092 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 12, 2026
Decision Date October 07, 2026
Days to Decision 268 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized Yes - Predetermined Change Control Plan authorized FDA has pre-authorized specific future modifications to this device, a pathway common in AI/SaMD devices.
Regulatory Context
Review time vs. panel average
161d slower than avg
Panel avg: 107d · This submission: 268d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. PCCP authorized - AI/SaMD pathway.

LNH Device Classification - Class 2, Special Controls

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 1109
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K260092.
ECHELON Synergy
K262902 · Fujifilm Corporation · Oct 2026
SwiftSight-BodyComposition
K261612 · Airs Medical, Inc. · Oct 2026
APERTO Lucent MRI System
K261283 · Fujifilm Corporation · Sep 2026
Embrace Vision Neonatal MRI System
K261758 · Aspect Imaging, Ltd. · Sep 2026
MAGNETOM Free.Max
K260758 · Siemens Shenzhen Magnetic Resonance , Ltd. · Sep 2026
Swoop® Portable MR Imaging® System
K262622 · Hyperfine, Inc. · Aug 2026